| D010051 |
Ovarian Neoplasms |
Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. |
Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm |
|
| D004789 |
Enzyme Activation |
Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. |
Activation, Enzyme,Activations, Enzyme,Enzyme Activations |
|
| D005260 |
Female |
|
Females |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D045744 |
Cell Line, Tumor |
A cell line derived from cultured tumor cells. |
Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines |
|
| D048369 |
MAP Kinase Kinase 1 |
An abundant 43-kDa mitogen-activated protein kinase kinase subtype with specificity for MITOGEN-ACTIVATED PROTEIN KINASE 1 and MITOGEN-ACTIVATED PROTEIN KINASE 3. |
MAP2K1 Protein,MAPK Kinase 1,MEK-1 Protein Kinase,MEK1 Protein Kinase,MKK-1 Protein Kinase,MKK1 Protein Kinase,Mitogen-Activated Protein Kinase Kinase 1,MEK 1 Protein Kinase,MKK 1 Protein Kinase,Mitogen Activated Protein Kinase Kinase 1 |
|
| D049109 |
Cell Proliferation |
All of the processes involved in increasing CELL NUMBER including CELL DIVISION. |
Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular |
|
| D055785 |
Gene Knockdown Techniques |
The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES. |
Gene Knock Down Techniques,Gene Knock Down,Gene Knock-Down,Gene Knock-Down Techniques,Gene Knockdown,Gene Knock Downs,Gene Knock-Down Technique,Gene Knock-Downs,Gene Knockdown Technique,Gene Knockdowns,Knock Down, Gene,Knock Downs, Gene,Knock-Down Technique, Gene,Knock-Down Techniques, Gene,Knock-Down, Gene,Knock-Downs, Gene,Knockdown Technique, Gene,Knockdown Techniques, Gene,Knockdown, Gene,Knockdowns, Gene,Technique, Gene Knock-Down,Technique, Gene Knockdown,Techniques, Gene Knock-Down,Techniques, Gene Knockdown |
|
| D019089 |
Stem Cell Factor |
A hematopoietic growth factor and the ligand of the cell surface c-kit protein (PROTO-ONCOGENE PROTEINS C-KIT). It is expressed during embryogenesis and is a growth factor for a number of cell types including the MAST CELLS and the MELANOCYTES in addition to the HEMATOPOIETIC STEM CELLS. |
Mast Cell Growth Factor,Steel Factor,c-kit Ligand,kit Ligand,c kit Ligand |
|
| D020929 |
Mitogen-Activated Protein Kinase Kinases |
A dual-specific protein kinase family whose members are components in protein kinase cascades activated by diverse stimuli. These MAPK kinases phosphorylate MITOGEN-ACTIVATED PROTEIN KINASES and are themselves phosphorylated by MAP KINASE KINASE KINASES. JNK kinases (also known as SAPK kinases) are a subfamily. |
MAP Kinase Kinases,MAPK Kinase,MAPK Kinases,MAPK-ERK Kinase,MAPK-ERK Kinases,MAPKKs,MEK,MEKs,Mitogen-Activated Protein Kinase Kinase,MAP-ERK Kinase,MAPKK,Map Kinase Kinase,Kinase Kinase, Map,Kinase Kinases, MAP,Kinase, MAP-ERK,Kinase, MAPK,Kinase, MAPK-ERK,Kinase, Map Kinase,Kinases, MAP Kinase,Kinases, MAPK,Kinases, MAPK-ERK,MAP ERK Kinase,MAPK ERK Kinase,MAPK ERK Kinases,Mitogen Activated Protein Kinase Kinase,Mitogen Activated Protein Kinase Kinases |
|
-transparent.png){kind=logo}
